Individual Study / POSPER

Prospective Study of Pravastatin in the Elderly at Risk

Prospective Study of Pravastatin in the Elderly at Risk

Initiatives -
The aim was to test the benefits of pravastatin treatment in an elderly cohort of men and women with, or at high risk of developing, cardiovascular disease and stroke. *Note: All published information has been collected from the article referenced in the Marker Paper box below. Therefore, there may be variations with more advanced versions of the study.*
Start Year
1997
End Year
2001

Members

Download
Investigators Contacts
  • Dr. Behnam Sabayan
    Northwestern University

Design

Study design
Patients' cohort
Follow Up
Follow-up was 3.2 years on average

Marker Paper

Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, Ford I, Gaw A, Hyland M, Jukema JW, Kamper AM, Macfarlane PW, Meinders AE, Norrie J, Packard CJ, Perry IJ, Stott DJ, Sweeney BJ, Twomey C, Westendorp RG; PROSPER study group. PROspective Study of Pravastatin in the Elderly at Risk. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet. 2002 Nov 23;360(9346):1623-30. doi: 10.1016/s0140-6736(02)11600-x.

PUBMED 12457784

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
649
Number of participants with biosamples
Supplementary Information
Aged 70-82 years

Access

Availability of data and biosamples

Data
Biosamples
Other